Rubric condition met: Two meta-analyses of controlled trials in healthy adults with a consistent direction (adverse).
In healthy adults given caffeine within hours of night-time sleep, a 2023 meta-analysis of 24 studies found caffeine added 9 minutes to the time taken to fall asleep, and a 2025 meta-analysis of 22 crossover trials of acute doses (956 participants) found 8.35 minutes. Both high and low doses lengthened sleep onset. A home trial found 400 mg disturbed sleep even 6 hours before bed. This grade describes a harmful effect.
How sure are we?
Evidence maturity: Maturity under review
The maturity label for this grade is under review.
Who paid for the studies
Mostly independent
Risk of bias
Not assessed: the 2023 and 2025 meta-analysis abstracts report no risk-of-bias rating and the full texts were not read
Trial registry check
Full search on November 15, 2026 (all 122 completed ClinicalTrials.gov records for sleep terms, all 302 ISRCTN caffeine records, PubMed registry-linked records): no preregistered independent trial of caffeine alone on sleep in healthy adults with published results found
Publication bias
Not assessed: no funnel or small-study test reported in the abstracts read
Outcome measured
A test score, rating scale or performance measure
Who was studied
Matched
Doses used in studies
Acute doses up to 400 mg, 0-6 hours before bed
Could rise: Already at the top grade (adverse); the maturity label is under review.
Could fall: Would move to B adverse if two adequately sized preregistered trials found no change in sleep onset at doses of 100 mg or more taken in the morning.
Science is provisional. This grade reflects the evidence we found as of . Next review: .
Maturity sits beside each grade. The grade says what the evidence shows; maturity says how much of it there is and how well it is confirmed.
Established
many trials from several independent teams, including at least one registered in advance
Emerging
two or more trials, or one large registered trial, not yet independently confirmed
Early signal
one trial, small pilots, or results only on secondary outcomes
Mechanistic only
lab, animal or biomarker data, or uncontrolled reports; no controlled human results
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.Show the numbers
Study
Year
Design
Participants
Result
Drake 2013
2013
RCT
not recorded
result not recorded
Gardiner 2023
2023
meta-analysis
not recorded
result not recorded
Chang 2025
2025
meta-analysis
956
result not recorded
Age- and dose-specific effects of caffeine on sleep: A meta-analysis of controlled crossover trials.
Chang YH, Cheng YC, Cheng WJ. Age- and dose-specific effects of caffeine on sleep: A meta-analysis of controlled crossover trials Sleep Med, 2025. PMID 41124973
Result not recorded
Design
Meta-analysis of 22 controlled crossover trials
Sample
n = 956
Population
Healthy adults
Funding
not stated
Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.
Drake C, Roehrs T, Shambroom J. Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed J Clin Sleep Med, 2013. PMID 24235903
The effect of caffeine on subsequent sleep: A systematic review and meta-analysis.
Gardiner C, Weakley J, Burke LM. The effect of caffeine on subsequent sleep: A systematic review and meta-analysis Sleep Med Rev, 2023. PMID 36870101
Result not recorded
Design
Systematic review and meta-analysis of 24 studies
Population
Adults (night-time sleep studies)
Funding
not stated
Search and history
Search (): caffeine[ti] AND sleep[ti] AND (meta-analysis[pt] OR systematic review[pt])
Graded A (awaiting approval)
A to A (approved): Editor sign-off November 16, 2026: grade matches the editor-approved final page
A, strong: what grade A means
At least one meta-analysis or three independent randomized trials in the relevant healthy population, pointing the same way, with low or some risk of bias, at doses legally available.